Stock listing
RGT Stock Price, News, Filings & Events — Argent Biopharma Ltd
Selected listing: RGT · ASX · AUD · AU
This page tracks Argent Biopharma Ltd's RGT:ASX listing on ASX in AUD for AU, including stock price context, company news, filings, investor events, AI research briefs, and market updates for investors following RGT:ASX. RGT:ASX is the stock-level entry point for investors researching Argent Biopharma Ltd, while company-level investor report content can remain shared across the same issuer's public listings. 6ix connects this selected listing to available company updates, filings, investor events, replay content, and AI research briefs so stock search leads to the relevant company context without making another exchange listing primary. Argent Biopharma Ltd, trading under the ticker RGT, is a public company based in Australia with a market capitalization of approximately AUD 4.89 million. The company focuses on biopharmaceutical development and innovation. Its activities are centered around advancing healthcare solutions and addressing unmet medical needs.
- Ticker
- RGT:ASX
- Asset type
- Stock
- Market cap
- $2.5M
- Sector
- Health Technology
- Industry
- Pharmaceuticals: Other
- Exchange
- ASX
- Currency
- AUD
Argent Biopharma Ltd RGT:ASX stock context
This page tracks Argent Biopharma Ltd's RGT:ASX listing on ASX in AUD for AU, including stock price context, company news, filings, investor events, AI research briefs, and market updates for investors following RGT:ASX. RGT:ASX is the stock-level entry point for investors researching Argent Biopharma Ltd, while company-level investor report content can remain shared across the same issuer's public listings. 6ix connects this selected listing to available company updates, filings, investor events, replay content, and AI research briefs so stock search leads to the relevant company context without making another exchange listing primary. Argent Biopharma Ltd, trading under the ticker RGT, is a public company based in Australia with a market capitalization of approximately AUD 4.89 million. The company focuses on biopharmaceutical development and innovation. Its activities are centered around advancing healthcare solutions and addressing unmet medical needs.
Latest news from Argent Biopharma Ltd
Appendix 4E and 2026 Annual Report
August 31, 2026
FDA-CVM Establish INAD File for CannEpil Veterinary Program
August 25, 2026
US Veterinary Development Programme for CannEpil Commences
August 5, 2026
CannEpil Global Licence Expands into Veterinary Healthcare
July 30, 2026
RGT Executes Global CannEpil Licensing Deal for US$5.5M
July 6, 2026
Research Argent Biopharma Ltd
Argent Biopharma Ltd investor report
Review AI stock analysis and investor report context for RGT:ASX.
Argent Biopharma Ltd company profile
View the public company page for Argent Biopharma Ltd on 6ix.
Argent Biopharma Ltd news
Read company news and market updates connected to Argent Biopharma Ltd.
Argent Biopharma Ltd investor events
Find investor webinars, events, and replay context for Argent Biopharma Ltd.
Alternate listings
RGTLF:OTC
US · USD
Alternate listing for Argent Biopharma Ltd; the primary context on this page is RGT:ASX.
A40A1Q:LS
DE · EUR
Alternate listing for Argent Biopharma Ltd; the primary context on this page is RGT:ASX.
A2ACB6:LSX
DE · EUR
Alternate listing for Argent Biopharma Ltd; the primary context on this page is RGT:ASX.
A40A1Q:LSX
DE · EUR
Alternate listing for Argent Biopharma Ltd; the primary context on this page is RGT:ASX.
H5O0:GETTEX
DE · EUR
Alternate listing for Argent Biopharma Ltd; the primary context on this page is RGT:ASX.
H5O0:DUS
DE · EUR
Alternate listing for Argent Biopharma Ltd; the primary context on this page is RGT:ASX.
H5O0:FWB
DE · EUR
Alternate listing for Argent Biopharma Ltd; the primary context on this page is RGT:ASX.
A2ACB6:LS
DE · EUR
Alternate listing for Argent Biopharma Ltd; the primary context on this page is RGT:ASX.
H5O0:SWB
DE · EUR
Alternate listing for Argent Biopharma Ltd; the primary context on this page is RGT:ASX.